Hedge Fund - Casdin Capital
Sage Therapeutics Inc. (SAGE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q3 (2023-09-30) | $0 | 0% | 0 | $28.88 |
| 2 | 2023 - Q2 (2023-06-30) | $4,231,800 | 0.36% | 90,000 | $49.75 |
| 3 | 2020 - Q2 (2020-06-30) | $0 | 0% | 0 | $36.29 |
| 4 | 2020 - Q1 (2020-03-31) | $11,057,000 | 1.17% | 385,000 | $57.91 |
| 5 | 2019 - Q4 (2019-12-31) | $16,604,000 | 1.52% | 230,000 | $123.02 |
| 6 | 2019 - Q3 (2019-09-30) | $56,116,000,000 | 5.8% | 400,000 | $167.28 |
| 7 | 2019 - Q2 (2019-06-30) | $73,236,000,000 | 6.85% | 400,000 | $170.63 |
| 8 | 2019 - Q1 (2019-03-31) | $63,620,000 | 6.98% | 400,000 | $144.81 |
| 9 | 2018 - Q4 (2018-12-31) | $29,886,000 | 5.11% | 312,000 | $114.81 |
| 10 | 2018 - Q3 (2018-09-30) | $44,070,000 | 5.35% | 312,000 | $154.35 |
| 11 | 2018 - Q2 (2018-06-30) | $39,133,000 | 5.47% | 250,000 | $156.99 |
| 12 | 2018 - Q1 (2018-03-31) | $40,268,000 | 7.08% | 250,000 | $169.79 |
| 13 | 2017 - Q4 (2017-12-31) | $41,178,000 | 10.02% | 250,000 | $96.95 |
| 14 | 2017 - Q3 (2017-09-30) | $14,952,000 | 4.22% | 240,000 | $78.54 |
| 15 | 2017 - Q2 (2017-06-30) | $20,308,000 | 7.51% | 255,000 | $72.29 |
| 16 | 2017 - Q1 (2017-03-31) | $18,123,000 | 10.69% | 255,000 | $58.58 |
| 17 | 2016 - Q4 (2016-12-31) | $13,250,000 | 10.94% | 259,500 | $47.13 |
| 18 | 2016 - Q3 (2016-09-30) | $12,272,000 | 9.93% | 266,500 | $40.70 |
| 19 | 2016 - Q2 (2016-06-30) | $6,885,000 | 6.85% | 228,500 | $33.35 |
| 20 | 2016 - Q1 (2016-03-31) | $6,059,000 | 6.95% | 189,000 | $35.20 |
| 21 | 2015 - Q4 (2015-12-31) | $8,338,000 | 7.36% | 143,011 | $49.54 |
The displayed share prices are average quarterly stock market prices.